PURPOSE: As the recommended radiation dose for non-small-cell lung cancer (NSCLC) increases, meeting dose constraints for critical structures like the brachial plexus becomes increasingly challenging, particularly for tumors in the superior sulcus. In this retrospective analysis, we compared dose-volume histogram information with the incidence of plexopathy to establish the maximum dose tolerated by the brachial plexus. METHODS AND MATERIALS: We identified 90 patients with NSCLC treated with definitive chemoradiation from March 2007 through September 2010, who had received >55 Gy to the brachial plexus. We used a multiatlas segmentation method combined with deformable image registration to delineate the brachial plexus on the original planning CT scans and scored plexopathy according to Common Terminology Criteria for Adverse Events version 4.03. RESULTS: Median radiation dose to the brachial plexus was 70 Gy (range, 56-87.5 Gy; 1.5-2.5 Gy/fraction). At a median follow-up time of 14.0 months, 14 patients (16%) had brachial plexopathy (8 patients [9%] had Grade 1, and 6 patients [7%] had Grade ≥2); median time to symptom onset was 6.5 months (range, 1.4-37.4 months). On multivariate analysis, receipt of a median brachial plexus dose of >69 Gy (odds ratio [OR] 10.091; 95% confidence interval [CI], 1.512-67.331; p = 0.005), a maximum dose of >75 Gy to 2 cm(3) of the brachial plexus (OR, 4.909; 95% CI, 0.966-24.952; p = 0.038), and the presence of plexopathy before irradiation (OR, 4.722; 95% CI, 1.267-17.606; p = 0.021) were independent predictors of brachial plexopathy. CONCLUSIONS: For lung cancers near the apical region, brachial plexopathy is a major concern for high-dose radiation therapy. We developed a computer-assisted image segmentation method that allows us to rapidly and consistently contour the brachial plexus and establish the dose limits to minimize the risk of brachial plexopathy. Our results could be used as a guideline in future prospective trials with high-dose radiation therapy for unresectable lung cancer.
PURPOSE: As the recommended radiation dose for non-small-cell lung cancer (NSCLC) increases, meeting dose constraints for critical structures like the brachial plexus becomes increasingly challenging, particularly for tumors in the superior sulcus. In this retrospective analysis, we compared dose-volume histogram information with the incidence of plexopathy to establish the maximum dose tolerated by the brachial plexus. METHODS AND MATERIALS: We identified 90 patients with NSCLC treated with definitive chemoradiation from March 2007 through September 2010, who had received >55 Gy to the brachial plexus. We used a multiatlas segmentation method combined with deformable image registration to delineate the brachial plexus on the original planning CT scans and scored plexopathy according to Common Terminology Criteria for Adverse Events version 4.03. RESULTS: Median radiation dose to the brachial plexus was 70 Gy (range, 56-87.5 Gy; 1.5-2.5 Gy/fraction). At a median follow-up time of 14.0 months, 14 patients (16%) had brachial plexopathy (8 patients [9%] had Grade 1, and 6 patients [7%] had Grade ≥2); median time to symptom onset was 6.5 months (range, 1.4-37.4 months). On multivariate analysis, receipt of a median brachial plexus dose of >69 Gy (odds ratio [OR] 10.091; 95% confidence interval [CI], 1.512-67.331; p = 0.005), a maximum dose of >75 Gy to 2 cm(3) of the brachial plexus (OR, 4.909; 95% CI, 0.966-24.952; p = 0.038), and the presence of plexopathy before irradiation (OR, 4.722; 95% CI, 1.267-17.606; p = 0.021) were independent predictors of brachial plexopathy. CONCLUSIONS: For lung cancers near the apical region, brachial plexopathy is a major concern for high-dose radiation therapy. We developed a computer-assisted image segmentation method that allows us to rapidly and consistently contour the brachial plexus and establish the dose limits to minimize the risk of brachial plexopathy. Our results could be used as a guideline in future prospective trials with high-dose radiation therapy for unresectable lung cancer.
Authors: T Le Chevalier; R Arriagada; M Tarayre; M J Lacombe-Terrier; A Laplanche; E Quoix; P Ruffie; M Martin; J Y Douillard Journal: J Natl Cancer Inst Date: 1992-01-01 Impact factor: 13.506
Authors: He Wang; Lei Dong; Ming Fwu Lii; Andrew L Lee; Renaud de Crevoisier; Radhe Mohan; James D Cox; Deborah A Kuban; Rex Cheung Journal: Int J Radiat Oncol Biol Phys Date: 2005-03-01 Impact factor: 7.038
Authors: C A Perez; K Stanley; P Rubin; S Kramer; L Brady; R Perez-Tamayo; G S Brown; J Concannon; M Rotman; H G Seydel Journal: Cancer Date: 1980-06-01 Impact factor: 6.860
Authors: Feng-Ming Spring Kong; Timothy Ritter; Douglas J Quint; Suresh Senan; Laurie E Gaspar; Ritsuko U Komaki; Coen W Hurkmans; Robert Timmerman; Andrea Bezjak; Jeffrey D Bradley; Benjamin Movsas; Lon Marsh; Paul Okunieff; Hak Choy; Walter J Curran Journal: Int J Radiat Oncol Biol Phys Date: 2010-10-08 Impact factor: 7.038
Authors: Marigdalia K Ramirez-Fort; Marc J Rogers; Roberto Santiago; Sean S Mahase; Melissa Mendez; Yi Zheng; Xiang Kong; James A Kashanian; M Junaid Niaz; Shearwood McClelland; Xiaodong Wu; Neil H Bander; Peter Schlegel; John P Mulhall; Christopher S Lange Journal: Rep Pract Oncol Radiother Date: 2020-03-19
Authors: Gregory Sharp; Karl D Fritscher; Vladimir Pekar; Marta Peroni; Nadya Shusharina; Harini Veeraraghavan; Jinzhong Yang Journal: Med Phys Date: 2014-05 Impact factor: 4.071
Authors: Joris Van de Velde; Tom Vercauteren; Werner De Gersem; Johan Wouters; Katrien Vandecasteele; Philippe Vuye; Frank Vanpachtenbeke; Katharina D'Herde; Ingrid Kerckaert; Wilfried De Neve; Tom Van Hoof Journal: Strahlenther Onkol Date: 2014-04-09 Impact factor: 3.621
Authors: Rachel B Ger; Jinzhong Yang; Yao Ding; Megan C Jacobsen; Clifton D Fuller; Rebecca M Howell; Heng Li; R Jason Stafford; Shouhao Zhou; Laurence E Court Journal: Med Phys Date: 2017-07-18 Impact factor: 4.071
Authors: Jinzhong Yang; Wendy A Woodward; Valerie K Reed; Eric A Strom; George H Perkins; Welela Tereffe; Thomas A Buchholz; Lifei Zhang; Peter Balter; Laurence E Court; X Allen Li; Lei Dong Journal: Int J Radiat Oncol Biol Phys Date: 2014-03-07 Impact factor: 7.038
Authors: Bindu V Manyam; Kyle Verdecchia; Kevin Rogacki; Chandana A Reddy; Tingliang Zhuang; Gregory M M Videtic; Joseph T Azok; Kevin L Stephans Journal: J Radiosurg SBRT Date: 2019